Patent assignee · US · COMPANY

Pathways Neuro Pharma, Inc.

2Patents
2Active
2Granted
42Portfolio score

Filing activity: Jun 9, 2020 → Mar 2, 2021

Most-cited patents

PatentTitleAreaCited byStatus
US11760788B2 Neuroreceptor compositions and methods of use Chemistry; Metallurgy 0 Active
US11701353B2 Methods, compositions, and uses of novel FYN kinase inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.